Phio Pharmaceuticals Corp.
PHIO
$1.09
$0.000.00%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
8/11/2026
-
The Cerbat Gem
8/11/2026
-
Newsfile Corp. - News Releases
8/8/2026
-
The Cerbat Gem
8/6/2026
-
Newsfile Corp. - News Releases
7/29/2026
-
The Cerbat Gem
7/22/2026
-
Newsfile Corp. - News Releases
7/22/2026
-
Newsfile Corp. - News Releases
7/21/2026
-
Newsfile Corp. - News Releases
7/15/2026
-
Newsfile Corp. - News Releases
7/12/2026
-
The Cerbat Gem
6/26/2026
-
Globe Newswire
6/26/2026
-
Newsfile Corp. - News Releases
6/25/2026
-
Newsfile Corp. - News Releases
6/24/2026
-
Newsfile Corp. - News Releases
6/23/2026
-
Globe Newswire
Phio Pharmaceuticals Announces Participation in the Life Sciences Investor Forum on June 24-25, 2026
6/18/2026
-
Newsfile Corp. - News Releases
5/26/2026
-
Newsfile Corp. - News Releases
5/19/2026
-
The Cerbat Gem
5/12/2026
-
Newsfile Corp. - News Releases
5/9/2026
-
The Cerbat Gem
5/7/2026
-
Seeking Alpha - Healthcare
5/7/2026
-
Newsfile Corp. - News Releases
4/23/2026
-
Newsfile Corp. - News Releases
4/13/2026
-
Newsfile Corp. - News Releases
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, August 6, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 9 and 13 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
610 947 0251
Address
411 Swedeland Road
Suite 23-1080
King of Prussia, PA 19406
Suite 23-1080
King of Prussia, PA 19406
Country
Year Founded
Business Description
Sector
Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound...
more